Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Clinical and Experimental Rheumatology|June 24, 2020
Impact of one-year treatment with biotechnological drugs on work ability in patients with rheumatoid arthritis in Italy: a prospective real-life studyMaria Manara, Roberto Caporali, Claudia Lomater, et al.
Journal of Market Access & Health Policy|June 20, 2018
Approaches to manage 'affordability' of high budget impact medicines in key EU countriesMathias Flume, Marc Bardou, Stefano Capri, et al.
European Journal of Public Health|October 17, 2014
Economic impact of adult obesity on health systems: a systematic reviewMaria Lucia Specchia, Maria Assunta Veneziano, Chiara Cadeddu, et al.
Journal of Market Access & Health Policy|May 27, 2026
EU-HTA-Why Do Words Matter?Mondher Toumi, Bruno Falissard, Steven Simoens, et al.
Clinical Chemistry and Laboratory Medicine|June 18, 2024
Screening for sickle cell disease: focus on newborn investigationsAndrea Mosca, Renata Paleari, Giovanni Palazzi, et al.
Journal of Market Access & Health Policy|May 27, 2026
Between Rigor and Relevance: Why the EU HTA Guidelines on Indirect Comparisons Miss the MarkSamuel Aballéa, Mondher Toumi, Piotr Wojciechowski, et al.
Applied Health Economics and Health Policy|October 22, 2016
Ethical Hurdles in the Prioritization of Oncology CareFolkert de Groot, Stefano Capri, Jean-Claude Castanier, et al.
European Journal of Public Health|April 1, 2019
Adjuvanted influenza vaccine for the Italian elderly in the 2018/19 season: an updated health technology assessmentChiara de Waure, Sara Boccalini, Paolo Bonanni, et al.
Pageof 4